Skip to main content
Biosenta Inc. logo

Biosenta Inc. — Investor Relations & Filings

Ticker · ZRO ISIN · CA09072N2023 CSE Manufacturing
Open in API
Filings indexed 152 across all filing types
Latest filing 2025-01-28 Regulatory Filings
Country CA Canada
Listing CSE ZRO

About Biosenta Inc.

https://www.biosenta.com

Biosenta Inc. develops, manufactures, and sells innovative, eco-friendly antimicrobial chemical compounds utilizing encapsulated nanotechnology. The company specializes in producing state-of-the-art solutions designed to eliminate harmful microorganisms for household and industrial applications. Biosenta's product portfolio includes Tri-Filler, a revolutionary anti-microbial filler used in soft and hard textiles. The company focuses on setting new global standards by delivering effective cleaning and material solutions that prioritize human and environmental safety.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 venture issuer certification (Form 52-109FV1) by the CEO attesting to the review and fair presentation of the annual filings (AIF, financial statements, MD&A). It is not the Annual Report itself, nor an announcement of publication, nor an audit report, but rather a regulatory compliance certificate. This falls under the general “Regulatory Filings” fallback category (RNS).
2025-01-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a CFO’s certification under Canadian NI 52-109 (Form 52-109FV1) for annual filings (AIF, financials, MD&A). It is not the annual report itself but a statutory certificate filed alongside regulatory reports. There is no presentation of financial results or dividends, nor is it a management change or earnings release. As a miscellaneous compliance filing, it falls under the general Regulatory Filings category (RNS).
2025-01-28 English
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is titled “Management’s Discussion & Analysis for the year ended September 30, 2024” and contains management’s detailed commentary on financial results, business strategy, significant events, and outlook. It is not the full annual report (10-K) but a standalone MD&A section. This matches the “Management Reports” category (MDA).
2025-01-28 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a completed OSC Form 13-502F1 submitted to the Ontario Securities Commission detailing calculations for the participation fee under OSC Rule 13-502 Fees. It is a regulatory form and does not represent an earnings release, management discussion, AGM material, or other standard corporate report. This is best classified as a general regulatory filing.
2025-01-28 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 1% confidence The document is titled “Consolidated Financial Statements for the years ended September 30, 2024 and 2023” and begins with an Independent Auditor’s Report from CAN Partners LLP, followed by complete consolidated statements of financial position, operations, changes in shareholders’ deficit, cash flows, and detailed notes. It is not the full annual management report or MD&A but rather a standalone audited set of IFRS financial statements with an auditor’s opinion. Therefore, it fits the definition of a standalone Audit Report / Information. FY 2024
2025-01-28 English
Letter from former auditor.pdf
Regulatory Filings
2024-09-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.